Hepatitis C virus associated hepatocellular carcinoma

M Khatun, R Ray, RB Ray - Advances in cancer research, 2021 - Elsevier
Liver cancer is a global problem and hepatocellular carcinoma (HCC) accounts for about
85% of this cancer. In the USA, etiologies and risk factors for HCC include chronic hepatitis …

Pan-genomics: Applications, challenges, and future prospects

D Barh, SC Soares, S Tiwari, VADC Azevedo - 2020 - books.google.com
Pan-genomics: Applications, Challenges, and Future Prospects covers current approaches,
challenges and future prospects of pan-genomics. The book discusses bioinformatics tools …

[HTML][HTML] Computer analysis of regulation of hepatocarcinoma marker genes hypermethylated by HCV proteins

EA Antropova, TM Khlebodarova… - Vavilov Journal of …, 2022 - ncbi.nlm.nih.gov
Hepatitis C virus (HCV) is a risk factor that leads to hepatocellular carcinoma (HCC)
development. Epigenetic changes are known to play an important role in the molecular …

Impact of IL28 genotypes and modeling the interactions of HCV core protein on treatment of hepatitis C

T Hashempour, B Dehghani, Z Musavi… - Interdisciplinary …, 2020 - Springer
Background Mutations in the core CVR region of hepatitis C virus (HCV) and polymorphisms
of interleukin 28B (IL28B) are associated with progression toward liver disease and in …

MicroRNA let-7b inhibits hepatitis C virus and induces apoptosis in human hepatoma cells

M Jamalidoust, M Shafaati, M Kalani, M Zare… - Molecular Biology …, 2022 - Springer
Abstract Background Small non-coding RNAs have emerged as essential modulators of viral
infections such as hepatitis C virus (HCV). Cellular miRNAs directly regulate the viral …

HMGB1 and SEPP1 as predictors of hepatocellular carcinoma in patients with viral C hepatitis: Effect of DAAs

NI Rizk, MS Al-aliaa, AR El-Ansary… - Clinical biochemistry, 2019 - Elsevier
Background Hepatitis C viral infection (HCV) and hepatocellular carcinoma (HCC) are
potential health problems. New directly acting antivirals (DAAs) changed HCV treatment …

Hepatitis C Virus mediated metastasis in hepatocellular carcinoma as a therapeutic target for cancer management

L Khera, C Paul, R Kaul - Current Drug Metabolism, 2018 - ingentaconnect.com
Background: Hepatocellular carcinoma (HCC) is one of the most common causes of cancer
associated deaths. Prognosis is relatively poor in cases where Hepatitis C Virus (HCV) is …

[HTML][HTML] Oncogenic Wnt3a: A promising specific biomarker in hepatocellular carcinoma

M Yao, M Fang, WJ Zheng, DF Yao - Hepatoma Research, 2018 - oaepublish.com
Hepatocellular carcinoma (HCC) is still one of the most common and rapidly fatal
malignancies worldwide with a multi-factorial, multi-step, complex process, and poor …

Pan-interactomics and its applications

GP Srivastava, N Yadav, BNS Yadav, RK Yadav… - … , Challenges, and Future …, 2020 - Elsevier
Cellular activities are an outcome of the series of biochemical communications in the
sequential web. Compendious study of the whole set of molecular interaction networks is …

The risk of hepatocellular carcinoma after sustained virological response in patients treated with the new direct-acting antiviral drugs: should we be worry about it?

JR Blanco, A Rivero-Juárez - Expert Review of Anti-infective …, 2016 - Taylor & Francis
Hepatocellular carcinoma (HCC) is a serious complication in the natural history of chronic
hepatitis C virus (HCV), and cirrhosis is the strongest risk factor [1]. Although different …